Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM3WG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerSourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30 count) with a ceiling value of $14,592.57. This contract was awarded on February 4, 2026, with an ultimate completion date of February 26, 2026. The award was made on a non-set-aside, competitive basis, and performance will be executed from AmerSourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerSourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates consistent capability to deliver a wide range of pharmaceutical products across multiple therapeutic domains on a competitive basis. This specific delivery order for Vyndamax, a pharmaceutical treatment product, represents one of numerous task orders placed against the parent IDC to fulfill essential medical supply requirements for Department of Defense and other federal healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FM3WG?
SPE2DR26FM3WG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FM3WG worth?
The government has obligated $14,593 on SPE2DR26FM3WG.
Is contract SPE2DR26FM3WG an order under another contract?
Yes. SPE2DR26FM3WG is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3WG competed?
The extent of competition for SPE2DR26FM3WG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award